Novartis Names Narasimhan CEO as Jimenez Retires

The video discusses Joe Jimenez, the current CEO of Novartis, highlighting his background and career path from Harvard to McKinsey and his rise within Novartis. It also covers the challenges Novartis faces, including underperformance in Europe, a pipeline of potential blockbuster drugs, and strategic decisions regarding its Alcon eyecare division and stake in Roche. The company is at a critical juncture, aiming for a return to growth in 2018.

Who is the current CEO of Novartis and what is his background?

What challenges is Novartis currently facing?

What is the significance of Novartis's pipeline of potential blockbusters?

What critical decisions is Novartis facing regarding its Alcon eyecare division?

What does the future look like for Novartis in terms of growth?